These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15631881)

  • 1. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status.
    Lee WY; Suh JY; Rhee EJ; Park JS; Sung KC; Kim SW
    Arch Med Res; 2004; 35(6):540-5. PubMed ID: 15631881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of thyroid status on serum apolipoprotein A-I-containing lipoprotein particles.
    Ozata M; Yildirimkaya M; Yilmaz K; Kutluay T; Corakci A; Beyhan Z; Gundogan MA
    Horm Metab Res; 1998 Apr; 30(4):217-21. PubMed ID: 9623637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of low-density lipoprotein (LDL) particle size to thyroid function status in Koreans.
    Kim CS; Kang JG; Lee SJ; Ihm SH; Yoo HJ; Nam JS; Ahn CW; Kim KR
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):130-6. PubMed ID: 19178521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism.
    Altinova AE; Törüner FB; Aktürk M; Bukan N; Cakir N; Ayvaz G; Arslan M
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):530-5. PubMed ID: 16984248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between lipoprotein(a) and thyroid function status in the general population.
    Lippi G; Targher G; Montagnana M; Salvagno GL; Guidi GC
    Arch Med Res; 2007 Nov; 38(8):905-6; author reply 907-8. PubMed ID: 17923276
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipoprotein (a) studies in thyroid diseases].
    Boda J; Paragh G; Szabó J; Mezösi E; Nagy E
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2307-9. PubMed ID: 9340577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
    J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Kähönen M; Solakivi T; Helenius H; Jula A; Marniemi J; Taittonen L; Laitinen T; Nikkari T; Raitakari OT
    J Am Coll Cardiol; 2008 Jul; 52(4):293-9. PubMed ID: 18634985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) levels in thyroid dysfunction before and after treatment.
    Sucić M; Bozikov V; Mesić R; Sokolić L
    Croat Med J; 1998 Mar; 39(1):19-22. PubMed ID: 9475802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Apr; 54(2):77-81. PubMed ID: 10378018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I positively associated with diabetes in women independently of apolipoprotein E genotype and apolipoprotein B levels.
    Onat A; Kömürcü-Bayrak E; Can G; Küçükdurmaz Z; Hergenç G; Erginel-Unaltuna N
    Nutrition; 2010 Oct; 26(10):975-80. PubMed ID: 20116212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
    Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
    Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
    Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
    Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic profile in preeclampsia.
    Var A; Kuşcu NK; Koyuncu F; Uyanik BS; Onur E; Yildirim Y; Oruç S
    Arch Gynecol Obstet; 2003 Apr; 268(1):45-7. PubMed ID: 12673475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of apolipoproteins in patients with thyroid dysfunction.
    Tada H; Irie Y; Yagoro A; Ohya H; Hayashi S; Fushimi R; Tamaki H; Amino N
    Thyroidology; 1994 Dec; 6(3):93-7. PubMed ID: 7545001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic liver disease prevents the development of atherosclerosis in spite the risk factor].
    Matsumata T; Suehiro T; Funahashi S; Maeda T; Itasaka H; Muto Y
    Fukuoka Igaku Zasshi; 1998 Oct; 89(10):292-7. PubMed ID: 9844272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.